• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)

48.61 +0.71 (+1.48%)
Streaming Delayed Price Updated: 10:20 AM EDT, Apr 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 201,939
Open 47.87
Bid (Size) 48.60 (200)
Ask (Size) 48.64 (200)
Prev. Close 47.90
Today's Range 47.87 - 48.62
52wk Range 31.58 - 49.06
Shares Outstanding 388,132,400
Dividend Yield 1.93%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
April 10, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali... 
Via StockStory
News headline image
Branded Pharmaceuticals Stocks Q4 Teardown: Royalty Pharma (NASDAQ:RPRX) Vs The Rest
April 07, 2026
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence Intellectual Property

Performance

YTD
+25.1%
+25.1%
1 Month
+6.5%
+6.5%
3 Month
+20.7%
+20.7%
6 Month
+37.2%
+37.2%
1 Year
+50.5%
+50.5%

More News

Read More
News headline image
1 Value Stock for Long-Term Investors and 2 Facing Challenges
April 03, 2026
Via StockStory
News headline image
1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm
March 31, 2026
Via StockStory
Topics Energy
Royalty Pharma PLC (NASDAQ:RPRX) Emerges as a Compelling Value Investment ↗
March 27, 2026
Via Chartmill
ROYALTY PHARMA PLC-CL A (NASDAQ:RPRX) Shows High Technical and Setup Ratings Ahead of Potential Breakout ↗
March 18, 2026
Via Chartmill
Royalty Pharma PLC-CL A (NASDAQ:RPRX) Shares Dip Despite Strong Portfolio Growth and 2026 Guidance Beat ↗
February 11, 2026
Via Chartmill
News headline image
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
March 30, 2026
From Royalty Pharma plc
Via GlobeNewswire
News headline image
The Brain Barrier Broken: Inside Denali Therapeutics’ Landmark FDA Approval of AVLAYAH
March 26, 2026
Via Finterra
Topics Economy Initial Public Offering
News headline image
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q4 Earnings?
March 25, 2026
Via StockStory
Topics Artificial Intelligence Stocks Supply Chain
News headline image
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
March 23, 2026
From Royalty Pharma plc
Via GlobeNewswire
News headline image
Royalty Pharma Announces Expansion of Leadership Team
March 17, 2026
From Royalty Pharma plc
Via GlobeNewswire
News headline image
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
March 02, 2026
From Royalty Pharma plc
Via GlobeNewswire
News headline image
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
March 02, 2026
From Royalty Pharma plc
Via GlobeNewswire
News headline image
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
March 02, 2026
From Zymeworks Inc.
Via GlobeNewswire
News headline image
Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference
February 26, 2026
From Royalty Pharma plc
Via GlobeNewswire
News headline image
3 Healthcare Stocks Walking a Fine Line
February 18, 2026
Via StockStory
Topics Stocks
News headline image
5 Insightful Analyst Questions From Royalty Pharma’s Q4 Earnings Call
February 18, 2026
Via StockStory
Topics Earnings
News headline image
Patient Capital Bet Heavily on Chime Financial (CHYM) With a 2.04 Million Share Purchase ↗
February 14, 2026
Via The Motley Fool
News headline image
Royalty Pharma (RPRX) Q4 2025 Earnings Transcript ↗
February 11, 2026
Via The Motley Fool
Topics Bonds
News headline image
Royalty Pharma (NASDAQ:RPRX) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings
February 11, 2026
Via StockStory
News headline image
Royalty Pharma Reports Q4 and Full Year 2025 Results
February 11, 2026
From Royalty Pharma plc
Via GlobeNewswire
News headline image
What To Expect From Royalty Pharma’s (RPRX) Q4 Earnings
February 09, 2026
Via StockStory
Topics World Trade
News headline image
3 Mid-Cap Stocks We Keep Off Our Radar
February 05, 2026
Via StockStory
News headline image
3 Profitable Stocks with Open Questions
January 20, 2026
Via StockStory

Frequently Asked Questions

Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?
Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.
What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?
Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?
The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market
What is the current price of Royalty Pharma plc - Class A Ordinary Shares?
The current price of Royalty Pharma plc - Class A Ordinary Shares is 48.61
When was Royalty Pharma plc - Class A Ordinary Shares last traded?
The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 04/13/26 10:20 AM ET
What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?
The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 18.87B
How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?
Royalty Pharma plc - Class A Ordinary Shares has 19B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap